AbbVievsSANUWAVE Health

ABBV and SNWV stock compared: price, dividend, valuation and results, from SEC filings.

SNWV

SANUWAVE Health, Inc.

$1.81

Value $16M

-0.55%
SNWV's page

AbbVie (ABBV) has a market value of $521B and SANUWAVE Health (SNWV) $16M. Over the last year, with dividends, ABBV moved +30.6% and SNWV -94.5%. The P/E is 50.6 for ABBV and 3.7 for SNWV. Dividend yield: ABBV 2.35%, SNWV none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$521B

    SNWV$16M

    ABBV is 33,481 times SNWV

  • Revenue, 12 months

    ABBV$66.0B

    SNWV$41M

    ABBV is 1,597 times SNWV

  • Net income, 12 months

    ABBV$10.3B

    SNWV$4.2M

    ABBV is 2,489 times SNWV

  • Operating margin

    ABBV32.2%

    SNWV-1.1%

    33.3 points apart

  • ROIC

    ABBV25.7%

    SNWV-2.4%

    28.1 points apart

  • P/E

    ABBV50.6

    SNWV3.7

    ABBV is 14 times SNWV

  • Dividend yield

    ABBV2.4%

    SNWV0.0%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+30.6%

SNWV-94.5%

050100DecFebAprJunAugOct
Returns by period
PeriodABBVWith dividendsSNWVWith dividends
1 year since November 14, 2025+30.6%Price +26.8%-94.5%Price -94.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieSNWVSANUWAVE Health

Valuation

ABBVSNWV
Valuation
Price$294.55$1.81
Market value$521B$16M
Enterprise value (EV)$591B$26M
P/E50.63.7
P/E, 5-year median57.0–
P/B–5.5
EV/EBIT27.8–
Free cash flow yield3.6%16.7%

Results and growth

ABBVSNWV
Results and growth
Revenue, 12 months$66.0B$41M
Net income, 12 months$10.3B$4.2M
Free cash flow, 12 months$18.9B$2.6M
Earnings per share, 12 months$5.81-$0.21
Revenue growth, year on year8.6%35.0%
Revenue growth a year, past+5.9%over 5 years+61.1%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVSNWV
Margins and returns on capital
Gross margin73.7%76.2%
Operating margin32.2%-1.1%
Net margin15.7%10.1%
ROIC25.7%-2.4%
ROE–1,383.2%

Balance sheet

ABBVSNWV
Balance sheet
Cash$10.8B$6.6M
Total debt$80.9B$18M
Net debt / EBITDA3.220.0
Interest cover7.1×–

Dividends and buybacks

ABBVSNWV
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or SNWV

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or SANUWAVE Health?

By market value, AbbVie ($521B) is about 33,481.0 times SANUWAVE Health ($16M), at today's prices.

How did ABBV and SNWV stock do over the last 1 years?

Since November 14, 2025, ABBV's price moved +26.8% and SNWV's -94.5%. With dividends: ABBV +30.6% (+30.6% a year), SNWV -94.5% (-94.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or SNWV?

The dividend yield at today's price is 2.35% for AbbVie and none for SANUWAVE Health. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and SNWV?

At today's price, the P/E is 50.6 for ABBV and 3.7 for SNWV. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or SANUWAVE Health?

Over the last twelve months, the net margin was 15.7% for AbbVie and 10.1% for SANUWAVE Health, and the operating margin 32.2% and -1.1%. Revenue was $66.0B and $41M.

Which is the better investment, AbbVie or SANUWAVE Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.